Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

CERILLIANT™ Dehydro Aripiprazole-D8 Solution, 100 μg/mL (Methanol with 5% 1 N HCl), Sold by MilliporeSigma™ Supelco™

Certified reference material

Supplier:  MilliporeSigma Supelco D1781ML

Catalog No. 01-001-253


Due to product restrictions, please to purchase or view availability for this product.


Description

Description

This stable-labeled internal standard is suitable for use in LC/MS or GC/MS applications including forensic or clinical toxicology analysis and urine drug testing. Dehydro Aripiprazole is the primary, active metabolite of aripiprazole, marketed as the atypical antipsychotic Abilify™ for the treatment of schizophrenia, bipolar disorder, and clinical depression.
Specifications

Specifications

67-56-1
100 μg/mL (methanol with 5% 1 N HCl)
Ampule
9.7°C (49.5°F) - closed cup
C23H17D8Cl2N3O2
454.42
1 mL
Product Suggestions

Product Suggestions

Safety and Handling

Safety and Handling

H331-H370

H311

Recommended Storage : -20°C

SDS
Documents

Documents

Product Certifications
Promotions

Promotions

missing translation for 'provideContentCorrection'

We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.

missing translation for 'productTitle'

CERILLIANT is a registered trademark of Cerilliant Corporation